The DOI matches its Crossref record; 49 of the 53 references it cites were found in a registry or an index; 19 of the 37 sources its claims cite were checked for support.
The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial.
Open accessAbstract
Background: Multiple Sclerosis has a great impact on psychological functioning of patients and can be associated with various mental health disorders and symptoms. The most prevalent one is depression, which ranges from 15 to 47%. Mindfulness Based Interventions are a relatively brief and cost-effective program that has been studied in patients with several chronic diseases and recently also in patients with Multiple Sclerosis. Mindfulness Based Interventions are based on the assumption that a non-judgmental awareness and acceptance of one's moment-to-moment experience can have a positive effect on the adaptation to the disease, reducing the psychological burden and improving patients' quality of life. Several studies concluded that Mindfulness Based Interventions can be beneficial in terms of improving both psychological and psychical aspects of Multiple Sclerosis, but none of them compared the intervention with an active control group. The primary objective of the study is to evaluate the efficacy of a group-based Mindfulness Based Intervention on depressive symptoms in patients with Multiple Sclerosis, as compared with an active control group.Methods: The study design is a randomized controlled clinical trial. Eighty-eight patients with Multiple Sclerosis and depressive symptoms will be recruited and randomized to either Mindfulness Based Intervention or an active control group. The latter is designed to control for non-specific elements of the intervention and it comprises psycho-education and relaxation techniques. The primary outcome is the reduction of depressive symptoms as measured via the Beck Depressive Inventory-II. Secondary outcome measures are level of quality of life, anxiety, perceived stress, illness perception, fatigue and quality of interpersonal relationship. Outcomes will be assessed at baseline, after treatment and 6 months after the end of the treatment. Caregivers will participate in groups together with patients.Discussion: As far as we know this trial will be the first randomized controlled trial testing the efficacy of group-based Mindfulness Based Intervention for patients with Multiple Sclerosis with a comparison with an active control group with a specific focus on depressive symptoms.Trial Registration: NCT02611401.
Overview
CoChat Summary
## TL;DR
This paper is a randomized controlled trial protocol testing a group-based mindfulness intervention for depressive symptoms in 88 people with multiple sclerosis (MS), compared with an active control group. It also includes caregivers and plans to measure whether effects on depression and related outcomes persist to 6 months after treatment.
## Key findings
- The study is designed to enroll 88 patients with MS and depressive symptoms and randomize them 1:1 to mindfulness-based intervention (MBI) or active control.
- The primary outcome is change in Beck Depression Inventory-II (BDI-II) scores from baseline to 6-month follow-up (T2), plus the proportion with BDI-II > 13 at T2.
- The intervention consists of 8 weekly 3-hour sessions; the MBI also includes one additional 7-hour all-day session and daily 45-minute homework.
- The sample-size calculation assumes power = 0.80, significance = 0.05, and a minimum of 44 patients per group based on an effect size of 0.54; the authors expect screening of at least 600 patients to obtain the needed sample.
## Methods
- Design: Randomized controlled clinical trial with allocation concealment and blinded evaluators; outcomes assessed at baseline (T0), post-treatment (T1), and 6 months after treatment (T2).
- Sample: 88 MS patients aged 18–65 with depressive symptoms (screening cutoff BDI-II > 13), from a center serving about 1500 MS patients; caregivers/family members join the same assigned group.
- Analysis: Intention-to-treat analyses; repeated-measures multivariate ANCOVA for longitudinal and between-group comparisons, and chi-square tests for the proportion no longer meeting depression cutoff.
## Limitations
- The paper states that a main limitation is the exclusion of patients with severe disability, because the intervention requires mobility that is at least partially preserved.
- The paper also states that no neuroimaging or neurobiological assessments are planned.
- Evident from the protocol: this is a study protocol, not results, so it does not report trial outcomes yet.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
12 Valid · 2 Not valid · 10 Not checked · 16 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A Cochrane review [17] and a recent meta-analysis [18] identified that Cognitive Behavioural Therapy (CBT) had a moderate effect on depression.”
§ The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial > Background
What the sources say
- Partly supportedcites [17] Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev. 2006;1:CD004431. sourceExperimental — accuracy not yet measured
The Discussion (Mini-review 4; page unavailable) reports that two small CBT trials in people with MS found improvements in depression, and that a fixed-effects meta-analysis found an improvement. It does not characterize the effect as moderate; it also notes substantial heterogeneity and that a random-effects reanalysis was not statistically significant. (LLM, conf=0.86)
- Partly supportedcites [18] Fiest KM, Walker JR, Bernstein CN, Graff LA, Zarychanski R, Abou-Setta AM, et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord. 2016;5:12–26. sourceExperimental — accuracy not yet measured
The Results report a moderate reduction in depression severity across nine psychological-intervention trials in people with MS (SMD −0.45). Section 3.3 says CBT was used in eight trials, but the pooled estimate also includes other psychological interventions; the paper does not establish that effect size for CBT alone. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Statistical power calculation was based on previous studies [28, 48]: assuming power =0.80 and 0.05 significance, a minimal sample size of 44 patients/group will be required, based on an effect size of 0.54.”
§ The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial > Methods > Intervention
What the sources say
- Partly supportedcites [28] Grossman P, Kappos L, Gensicke H, D’Souza M, Mohr DC, Penner IK, et al. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology. 2010;75:1141–9. sourceExperimental — accuracy not yet measured
The Methods (Analysis) report a power calculation using power = 0.8, but specify a minimum of 70 patients per group and an effect size of 0.53—not 44 per group and 0.54. The passage does not state a 0.05 significance level. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [48] Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res. 2004;57:35–43. source
plainn = 44- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“but none of them compared the intervention with an active control group.”
- Also stated in: § Background · plain
“The major limit pointed out by all these studies is the absence of a comparison of MBI intervention with an active control group.”
§ The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial > Abstract > Background
What the sources say
- Supportedcites [20] Simpson R, Booth J, Lawrence M, Byrne S, Mair F, Mercer S. Mindfulness based interventions in multiple sclerosis--a systematic review. BMC Neurol. 2014;14:15. source
The Results, under Study characteristics, explicitly state that none of the three included studies compared mindfulness-based interventions with an active intervention. This directly supports the claim about active control groups in the reviewed MS studies. (LLM, conf=0.95)
- Supportedcites [21] Levin AB, Hadgkiss EJ, Weiland TJ, Jelinek GA. Meditation as an adjunct to the management of multiple sclerosis. Neurol Res Int. 2014;2014:704691. source
The Results (§3.1–3.2; page unavailable) describe the comparison groups as receiving usual care, normal therapy, or standard care; the other intervention study had no control group. The review also identifies the lack of a sham control in the controlled studies, supporting the claim that none used an active control group. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Background · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“Recently two systematic reviews [20, 21] focused on the efficacy of MBIs in MS patients, concluding that MBIs can be beneficial, especially in terms of improving the QoL, mental health parameters (such as anxiety and depression) and physical parameters (as fatigue).”
§ The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial > Background
What the sources say
- Supportedcites [20] Simpson R, Booth J, Lawrence M, Byrne S, Mair F, Mercer S. Mindfulness based interventions in multiple sclerosis--a systematic review. BMC Neurol. 2014;14:15. source
The Conclusions state that, although evidence is limited, MBIs can benefit people with MS in quality of life, mental health, and some physical aspects of the condition. The Discussion identifies improvements in anxiety, depression, and fatigue, matching the examples in the citing sentence. (LLM, conf=0.94)
- Supportedcites [21] Levin AB, Hadgkiss EJ, Weiland TJ, Jelinek GA. Meditation as an adjunct to the management of multiple sclerosis. Neurol Res Int. 2014;2014:704691. source
The Results (§3.1) report improved quality of life and lower fatigue, depression, and anxiety after mindfulness meditation compared with usual care in a trial of people with MS. The Discussion (§4) concludes that meditation appears to improve quality of life and may help manage fatigue and depression, while noting weaknesses in the evidence. (LLM, conf=0.92)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“As highlighted by previous study [19, 26], MBIs may be more effective and useful in populations with mood disorders.”
§ The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial > Background
What the sources say
- Supportedcites [19] Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol. 2010;78:169–83. source
The Discussion states that mindfulness-based therapy was most efficacious for reducing anxiety and depression symptoms in populations with mood or anxiety disorders. It also reports large effect sizes in patients with those disorders, supporting the hedged claim about usefulness in populations with mood disorders. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [26] Schirda B, Nicholas JA, Prakash RS. Examining trait mindfulness, emotion dysregulation, and quality of life in multiple sclerosis. Health Psychol. 2015;34:1107–15. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
5 more claims
Create a free account to see all 40 claims and every source verdict.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 13
Citations
Cites
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Using Self-Report Assessment Methods to Explore Facets of Mindfulness
Baer, R. A., Smith, G. T., Hopkins, J., Krietemeyer, J., & Toney, L. (2006) · Assessment · doi:10.1177/1073191105283504 · Cited by 7,511 · cited 3×
“Secondary outcome measures will be the comparison of the scores of FAMS, BAI, FSS, IIP, IPQ-Brief, PSS, PTGI and FFMQ of the two groups at T0, T1 and T2.”
BackgroundThe posttraumatic growth inventory: measuring the positive legacy of trauma
Tedeschi, R. G., & Calhoun, L. G. (1996) · Journal of Traumatic Stress · doi:10.1002/jts.2490090305 · Cited by 7,061 · cited 4×
“Secondary outcome measures will be the comparison of the scores of FAMS, BAI, FSS, IIP, IPQ-Brief, PSS, PTGI and FFMQ of the two groups at T0, T1 and T2.”
BackgroundInfluentialKrupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
New Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
Mindfulness-based stress reduction and health benefits
Grossman, P., Niemann, L., Schmidt, S., & Walach, H. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00573-7 · Cited by 3,958
The effect of mindfulness based therapy on anxiety and depression: A meta analytic review
Hofmann, S. G., Sawyer, A. T., Witt, A. A., & Oh, D. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0018555 · Cited by 3,846 · cited 2×
“As highlighted by previous study [19, 26], MBIs may be more effective and useful in populations with mood disorders.”
BackgroundMethodThe Brief Illness Perception Questionnaire
Broadbent, E., Petrie, K. J., Main, J., & Weinman, J. (2006) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2005.10.020 · Cited by 3,431
Effects of mindfulness on psychological health: A review of empirical studies
Keng, S.-L., Smoski, M. J., & Robins, C. J. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.04.006 · Cited by 2,687 · cited 2×
“In order to maximize the clinical utility in people with MS suffering from depressive symptoms, we will tailor mindfulness intervention on the needs of this specific population [44].”
Method
Research works printed but not linked: 5
- National Collaborating Centre for Mental Health (UK). Depression: The Treatment and Management of Depression in Adults (Updated Edition). Leicester (UK): British Psychological Society; 2010 [National Institute for Health and Clinical Excellence: Guidance].
- First MB, New York State Psychiatric Institute, Biometrics Research Department. Structured Clinical Interview for DSM-IV Axis I Disorders: SCID-I. Washington, DC. New York: American Psychiatric Press ; Biometrics Research Dept., New York State Psychiatric Institutute; 1997.
- Beck A, Steer R. Manual for the Beck Depression Inventory. San Antonio: Psychological Corporation; 1993.
- Murphy B, Herrman H, Hawthorne G, Pinzone T, Evert H. Australian WHOQoL Instruments: User’s Manual and Interpretation Guide. Melbourne: Australian WHOQoL Field Study Centre; 2000.
- Kurtz R. Body-Centered Psychotherapy: The Hakomi Method: The Integrated Use of Mindfulness, Nonviolence, and the Body. Revth ed. Mendocino: LifeRhythm; 2007.
Cited by
Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment
Solaro, C. M., Gamberini, G., & Masuccio, F. G. (2018) · CNS Drugs · doi:10.1007/s40263-018-0489-5 · Cited by 197
Online meditation training for people with multiple sclerosis: a randomized controlled trial
Cavalera, C., Rovaris, M., Mendozzi, L., Pugnetti, L., Garegnani, M., Castelnuovo, G., Molinari, E., & Pagnini, F. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458518761187 · Cited by 74
Nejati, S., Esfahani, S. R., Rahmani, S., Afrookhteh, G., & Hoveida, S. (2016) · Journal of Caring Sciences · doi:10.15171/jcs.2016.034 · Cited by 67
Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease
van Wamelen, D. J., Grigoriou, S., Chaudhuri, К. R., & Odin, P. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181476 · Cited by 56
Carletto, S., Tesio, V., Borghi, M., Francone, D., Scavelli, F., Bertino, G., Malucchi, S., Bertolotto, A., Oliva, F., Torta, R., et al. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.02083 · Cited by 49
“As previously described (Carletto et al., 2016), the inclusion criteria were: (1) definite diagnosis of MS (Mc Donald Criteria) (Polman et al., 2011) made or confirmed at the CReSM Unit at least 6 months prior the beginning of the study; (2) age between 18 and 65 years; (3) no evidence of clinical…”
MethodSelf-citation
Metadata
- Authors
- Carletto, S., Borghi, M., Francone, D., Scavelli, F., Bertino, G., Cavallo, M., Malucchi, S., Bertolotto, A., Oliva, F., & Ostacoli, L.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- Università degli Studi eCampus (IT)
- Corresponding author
- Carletto, Sara
- ORCID
- Venue
- BMC Neurology
- Published
- 2016-01-13
- Volume
- 16
- Issue
- 1
- Pages
- 7-7
- ISSN
- 1471-2377 (ISSN-L)
- PMC
- PMC4711056
- OpenAlex
- W2236803891
- Cited by
- 27
- References
- 53
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 5 · 2016: 3
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMC Neurology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, cc-by)
- IRIS eCampus Telematic University (Università degli Studi eCampus) (submittedVersion)
- Funders
- Fondazione Italiana Sclerosi Multipla (2009/R/19)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- multiple sclerosis, mindfulness-based interventions, depressive symptoms, depression, caregivers, group intervention, active control groups, psychoeducation, relaxation techniques, quality of life, anxiety, perceived stress, illness perception, fatigue, interpersonal relationships
- MeSH terms
- Adult, Clinical Protocols, Depression, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Randomized Controlled Trials as Topic, Caregivers, Outcome Assessment, Health Care, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial. https://app.cochat.ai/papers/10.1186/s12883-016-0528-0
- The paper
- Carletto, S., Borghi, M., Francone, D., Scavelli, F., Bertino, G., Cavallo, M., Malucchi, S., Bertolotto, A., Oliva, F., & Ostacoli, L. (2016). The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial. BMC Neurology. https://doi.org/10.1186/s12883-016-0528-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.